ORMP RSI Chart
Last 7 days
-4.2%
Last 30 days
-1.3%
Last 90 days
-26.7%
Trailing 12 Months
-44.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 2.8M | 4.9M | 3.1M | 1.3M |
2022 | 2.8M | 2.5M | 2.5M | 1.7M |
2021 | 2.9M | 2.9M | 2.7M | 2.8M |
2020 | 2.7M | 2.7M | 2.7M | 2.7M |
2019 | 2.6M | 2.6M | 2.7M | 2.7M |
2018 | 2.5M | 2.5M | 2.4M | 2.5M |
2017 | 1.5M | 2.0M | 2.5M | 2.5M |
2016 | 0 | 0 | 641.0K | 1.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 17, 2024 | reznick yehuda | acquired | - | - | 29,800 | - |
Jan 30, 2024 | aghion daniel | acquired | - | - | 3,750 | - |
Jan 04, 2024 | silberman david | acquired | - | - | 136,500 | chief financial officer |
Jan 04, 2024 | aghion daniel | acquired | - | - | 35,070 | - |
Jan 04, 2024 | shapiro benjamin | acquired | - | - | 35,070 | - |
Jan 04, 2024 | sank leonard | acquired | - | - | 39,325 | - |
Jan 04, 2024 | kidron nadav | acquired | - | - | 329,000 | president and ceo |
Jan 04, 2024 | kidron miriam | acquired | - | - | 295,500 | chief scientific officer |
Jan 04, 2024 | hexter joshua | acquired | - | - | 180,500 | coo & cbo |
Jan 04, 2024 | mayer arie | acquired | - | - | 39,325 | - |
Which funds bought or sold ORMP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Beacon Capital Management, LLC | unchanged | - | 67.00 | 639 | -% |
May 16, 2024 | Murchinson Ltd. | added | 31.38 | 1,602,620 | 4,028,120 | 0.34% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -9.52 | 31,712 | 252,359 | -% |
May 15, 2024 | Mariner, LLC | new | - | 30,788 | 30,788 | -% |
May 15, 2024 | STATE STREET CORP | added | 0.27 | 35,825 | 169,745 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -30.41 | -17,849 | 130,550 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | added | 5.77 | 211,251 | 838,192 | -% |
May 15, 2024 | BARCLAYS PLC | unchanged | - | 9,000 | 39,000 | -% |
May 15, 2024 | LM Advisors LLC | sold off | -100 | -5,775 | - | -% |
May 15, 2024 | Tyler-Stone Wealth Management | unchanged | - | 183 | 876 | -% |
Unveiling Oramed Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Oramed Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Oramed Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q3 | 2021Q2 | 2021Q2 | 2021Q1 | 2021Q1 | 2020Q4 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | - | - | - | 1,239,000 | 2,478,000 | 1,597,000 | 158,000 | 682,000 | 350,000 | 544,000 | 904,000 | 674,000 | 682,000 | 678,000 | 674,000 | 681,000 | 666,000 | 665,000 | 904,000 | 674,000 | 681,000 | 681,000 |
S&GA Expenses | -100.0% | - | 8,712,000 | -663,000 | 192,000 | 184,000 | 12,378,000 | 463,000 | 380,000 | 590,000 | 898,000 | 585,000 | 172,000 | 1,050,000 | 1,926,000 | 1,297,000 | - | 1,664,000 | - | 727,000 | 730,000 | 1,030,000 |
R&D Expenses | -33.2% | 1,179,000 | 1,766,000 | 957,000 | 1,821,000 | 4,427,000 | 9,037,000 | 5,347,000 | 9,179,000 | 5,836,000 | 9,037,000 | 6,410,000 | 6,086,000 | 8,872,000 | 3,198,000 | 5,502,000 | 6,168,000 | 3,869,000 | 6,889,000 | 5,774,000 | 2,968,000 | 1,925,000 |
EBITDA Margin | 0% | -5.93 | -5.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | 592,000 | - | 826,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | 2,558,000 | 308,000 | - | 100,000 | 617,000 | 122,000 | 128,000 | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -100.0% | - | 13,296,000 | -3,284,000 | - | - | -13,043,000 | -7,153,000 | - | - | - | - | -7,536,000 | - | - | -5,625,000 | - | -4,608,000 | - | - | -2,996,000 | -2,284,000 |
EBT Margin | 0% | -7.60 | -7.60 | -9.92 | -6.79 | -11.97 | -19.24 | -10.05 | -8.40 | -7.41 | -7.47 | -7.53 | -7.60 | -5.73 | -5.78 | -5.32 | -4.67 | - | - | - | - | - |
Net Income | -88.6% | 1,536,000 | 13,444,000 | -3,222,000 | -1,194,000 | -3,611,000 | -12,255,000 | -7,060,000 | -10,533,000 | -10,708,000 | -12,255,000 | -8,098,000 | -7,536,000 | -10,413,500 | -3,909,000 | -5,207,000 | -6,063,000 | -4,608,000 | -7,324,000 | -5,570,000 | -2,996,000 | -2,284,000 |
Net Income Margin | 95.0% | 7.88 | 4.04 | -6.49 | -4.91 | -12.01 | -23.39 | -16.35 | -16.83 | -13.76 | -13.78 | -10.87 | -9.90 | -9.45 | -7.37 | -7.96 | -8.10 | - | - | - | - | - |
Free Cashflow | -4.0% | -1,478,000 | -1,421,000 | -726,000 | -2,654,000 | -5,748,000 | -8,370,000 | -2,362,000 | -8,510,000 | -9,172,000 | -11,131,000 | -7,214,000 | -9,460,000 | -9,460,000 | -3,709,000 | -3,709,000 | -3,709,000 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Assets | -7.7% | 204 | 221 | 231 | 156 | 160 | 162 | 164 | 162 | 172 | 178 | 182 | 128 | 80.00 | 62.00 | 41.00 | 45.00 | 46.00 | 30.00 | 31.00 | 35.00 | 37.00 |
Current Assets | 8.9% | 177 | 163 | 176 | 151 | 155 | 157 | 160 | 135 | 144 | 148 | 152 | 95.00 | 72.00 | 57.00 | 36.00 | 41.00 | 41.00 | 29.00 | 31.00 | 33.00 | 27.00 |
Cash Equivalents | 105.1% | 19.00 | 9.00 | 5.00 | 7.00 | 24.00 | 40.00 | 33.00 | 30.00 | 28.00 | 27.00 | 32.00 | 77.00 | 57.00 | 34.00 | 15.00 | 19.00 | 9.00 | 6.00 | 3.00 | 3.00 | - |
Net PPE | -6.2% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Liabilities | -36.9% | 34.00 | 53.00 | 78.00 | 1.00 | 5.00 | 6.00 | 7.00 | 6.00 | 6.00 | 7.00 | 8.00 | 7.00 | 6.00 | 6.00 | 6.00 | 5.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Short Term Borrowings | -37.2% | 32.00 | 51.00 | 75.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 1.2% | 166 | 164 | 149 | 151 | 150 | 152 | 153 | 153 | 162 | 167 | 170 | 117 | 68.00 | 49.00 | 28.00 | 33.00 | 34.00 | 16.00 | 17.00 | 19.00 | - |
Retained Earnings | 1.0% | -156 | -157 | -170 | -167 | -166 | -163 | -154 | -147 | -136 | -126 | -122 | -114 | -108 | -102 | -98.18 | -92.61 | -89.62 | -87.33 | -83.65 | -81.10 | -78.82 |
Additional Paid-In Capital | 0.4% | 322 | 321 | 320 | 319 | 317 | 314 | 308 | 301 | 299 | 293 | 292 | 230 | 176 | 152 | 126 | 125 | 123 | 103 | 101 | 100 | 100 |
Shares Outstanding | 0.4% | 41.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 39.00 | 39.00 | 39.00 | 38.00 | 38.00 | 28.00 | 31.00 | - | - | - | - | - | - | - | - |
Minority Interest | 1.1% | -0.92 | -0.93 | -0.90 | -0.89 | -0.82 | -0.66 | -0.66 | -0.66 | -0.13 | 0.00 | 1.00 | 1.00 | 1.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 131 | - | - | - | 170 | - | - | - | - | - | 228 | - | - | - | 61.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q3 | 2021Q2 | 2021Q2 | 2021Q1 | 2021Q1 | 2020Q4 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -4.1% | -1,476 | -1,418 | -694 | -2,634 | -5,549 | -8,062 | -2,241 | -8,490 | -9,125 | -11,122 | -6,903 | - | -9,149 | - | - | -3,682 | -1,138 | -8,263 | -6,152 | -2,458 | -3,357 |
Share Based Compensation | -5.3% | 1,294 | 1,367 | 852 | 1,820 | 173 | 2,548 | 3,050 | 1,882 | 4,029 | 1,776 | - | - | 985 | - | 982 | - | 411 | - | 317 | -423 | 319 |
Cashflow From Investing | 0.0% | 29,998 | 29,997 | -75,122 | -14,710 | -13,203 | 11,260 | 1,229 | 10,363 | 7,359 | -99,248 | -99,048 | - | -43,311 | - | - | 10,753 | 294 | -2,405 | 1,199 | 10,963 | -13,237 |
Cashflow From Financing | 24.0% | -19,000 | -25,000 | 74,548 | - | 2,430 | 4,175 | 4,313 | -1.00 | 2,292 | 60,572 | 60,563 | - | 16,308 | - | - | 29,032 | 13,012 | 13,001 | 586 | 1,478 | 19,979 |
Interim Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
REVENUES | $ 666 | |
RESEARCH AND DEVELOPMENT EXPENSES | (1,179) | (4,427) |
SALES AND MARKETING EXPENSES | (184) | |
GENERAL AND ADMINISTRATIVE EXPENSES | (1,783) | (1,263) |
OPERATING LOSS | (2,962) | (5,208) |
INTEREST EXPENSES | (592) | |
FINANCIAL INCOME, NET | 5,088 | 1,597 |
NET INCOME (LOSS) | 1,534 | (3,611) |
NET INCOME (LOSS) ATTRIBUTABLE TO NON-CONTROLLING INTERESTS | (2) | (216) |
NET INCOME (LOSS) ATTRIBUTABLE TO STOCKHOLDERS | $ 1,536 | $ (3,395) |
BASIC INCOME (LOSS) PER SHARE OF COMMON STOCK (in Dollars per share) | $ 0.04 | $ (0.08) |
DILUTED INCOME (LOSS) PER SHARE OF COMMON STOCK (in Dollars per share) | $ 0.04 | $ (0.08) |
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC INCOME (LOSS) PER SHARE OF COMMON STOCK (in Shares) | 40,835,953 | 40,041,258 |
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING DILUTED INCOME (LOSS) PER SHARE OF COMMON STOCK (in Shares) | 41,564,007 | 40,041,258 |
Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 18,576 | $ 9,055 |
Short-term deposits | 80,285 | 95,279 |
Investments at fair value | 77,733 | 57,713 |
Prepaid expenses and other current assets | 501 | 537 |
Total current assets | 177,095 | 162,584 |
LONG-TERM ASSETS: | ||
Long-term deposits | 7 | 7 |
Investments at fair value | 19,544 | 51,035 |
Marketable securities | 2,026 | 1,807 |
Other non-marketable equity securities | 3,524 | 3,524 |
Amounts funded in respect of employee rights upon retirement | 29 | 27 |
Property and equipment, net | 819 | 873 |
Operating lease right-of-use assets | 608 | 694 |
Total long-term assets | 26,557 | 57,967 |
Total assets | 203,652 | 220,551 |
CURRENT LIABILITIES: | ||
Accounts payable and accrued expenses | 1,267 | 1,609 |
Short-term borrowings | 32,034 | 51,013 |
Payable to related parties | 1 | 325 |
Operating lease liabilities | 254 | 267 |
Total current liabilities | 33,556 | 53,214 |
LONG-TERM LIABILITIES: | ||
Long-term deferred revenues | 4,000 | 4,000 |
Employee rights upon retirement | 29 | 28 |
Provision for uncertain tax position | 11 | 11 |
Operating lease liabilities | 272 | 342 |
Other liabilities | 63 | 63 |
Total long-term liabilities | 4,375 | 4,444 |
COMMITMENTS (note 3) | ||
EQUITY ATTRIBUTABLE TO COMPANY’S STOCKHOLDERS: | ||
Common stock, $0.012 par value (60,000,000 authorized shares; 40,519,160 and 40,338,979 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively) | 487 | 485 |
Additional paid-in capital | 322,172 | 320,892 |
Accumulated deficit | (156,020) | (157,556) |
Total stockholders’ equity | 166,639 | 163,821 |
Non-controlling interests | (918) | (928) |
Total equity | 165,721 | 162,893 |
Total liabilities and equity | $ 203,652 | $ 220,551 |